METAvivor

Day 30 - Why We Need More Metastatic Research Metastatic breast cancer remains incurable, and patients don't have time to wait. More research is urgently needed to understand, prevent, and treat metastasis. Don’t ignore stage IV. #metavivor #METober

Day 29 - Clinical Trials: Research in Action Clinical trials make progress possible. Every cancer treatment available today started in a clinical trial, giving patients access to tomorrow’s therapies while advancing research. We must continue funding research & trials. #METober

Day 28 - MBC: Looking Good ≠ Feeling Good People with metastatic breast cancer (MBC) may look healthy while managing lifelong treatment and significant side effects. We need more effective, better-tolerated treatments that help patients live longer and live well. #METober

Day 27 No Evidence of Disease (NED) means scans show no detectable metastatic breast cancer, but it is not a cure. Hidden cancer cells may remain, which is why ongoing treatment and monitoring are often needed. Don’t ignore stage IV. #metavivor #METober

Day 26 - Inflammatory Breast Cancer Inflammatory Breast Cancer (IBC) is a rare, aggressive breast cancer that often causes redness, swelling, and skin changes instead of a lump. More research is urgently needed to improve outcomes and save lives. Don’t ignore stage IV. #METober

Day 25 - HER2 and Breast Cancer HER2+ breast cancer affects about 20% of patients. Despite this progress, side effects, treatment resistance, and changing HER2 status remain challenges, highlighting the need for safer, more effective therapies. Don’t ignore stage IV. #METober

Day 24 - Hormone Positive Breast Cancer (HR+) HR+ breast cancer treatments can be effective but often cause serious side effects. We need better, less toxic treatments that not only fight the cancer but protect quality of life. Don’t ignore stage IV. #metavivor #METober

Day 23 - Triple Negative Breast Cancer (TNBC) Triple negative breast cancer (TNBC) makes up about 15% of breast cancers. We need safer, more effective treatments—and that means more metastatic research. Don’t ignore stage IV. #metavivor #METober

Day 22 Brain Metastases in Breast Cancer One major challenge: the blood-brain barrier. Treatments currently work only for certain subtypes. We need more research to develop effective treatments for ALL patients with brain metastases. #metavivor #METober

Day 21 Liver Metastases in Breast Cancer About 1 in 4 MBC patients have liver metastases at diagnosis, and liver involvement affects many more over time. While treatments can help manage liver mets, more research is needed for better options and outcomes. #METober

Day 20 Breast cancer can spread to the lung nodules, lymphatics, or pleura. Every person diagnosed with breast cancer could breathe more easily if we fund the research that results in well-tolerated, effective treatments for all MBC patients. Don’t ignore stage IV. #METober

Day 19 Bone Metastases in Breast Cancer Bones are the most common site of breast cancer metastasis. Bone mets can cause severe pain, fractures, and other serious complications, often affecting the spine, ribs, and pelvis. Don’t ignore Stage IV. #METAvivor #MBC #METober

Day 18 Up until a few years ago, the National Cancer Institute (NCI), which is responsible for SEER, did little to modernize the registry. Thanks to advocacy efforts, Congressional Appropriations Committee Reports have called upon NCI to modernize the SEER Registry. #METober

Day 17 Research is what gives people with MBC hope. In this era of uncertainty around federal research funding, the work we do becomes even more important, but we cannot do it without our supporters. Please donate #UntilNoOneDiesFromMBC #METober

A world filled with light. An evening of hope. Over $500k raised for Metastatic Breast Cancer Research. Over 350 landmarks around the globe illuminated in pink, teal, and green. ▶️ Watch the replay! youtu.be/Xag5ACv0wLM?si=p4wI… #LightUpMBC

Day 16 - The Cancer Drug Parity Act would provide equal coverage for all cancer patients–regardless of how their treatments are administered. Have you faced challenges getting coverage for or affording Oral Oncology Drugs? Tell us your story! (metavivor.memfox.io/cancerdr…) #METober

Want to revisit the 2026 Stage IV Stampede & Summit, or couldn't attend and want to learn more about MBC advocacy? Explore our event recap: metavivor.org/events-campaig… #StageIVStampede #METAvivorStageIVStampede

On Global Lobular Breast Cancer Awareness Day, we call for more awareness and targeted research. Give now and be part of meaningful progress in #MBCresearch. Click the link in our bio! #LobularBreastCancer #MBC #BreastCancerAwareness #METAvivor #FundMBC

Day 15 Invasive Lobular Carcinoma (ILC) accounts for up to 15% of breast cancers. Unlike invasive ductal carcinoma (IDC), ILC cells grow in a single file and often don’t form a lump, making detection harder and easier to miss. #metavivor #METober

Day 14 Stage IV Stampede & Summit by the numbers On Oct 6, METAvivor advocates visited 49 Congressional offices to educate policy makers and their staff about MBC. Want to be more involved in advocacy? Visit our advocacy page here: metavivor.org/policy-advocac… #METober